Metformin in women at high risk of gestational diabetes mellitus

Diabetes Metab. 2018 Jun;44(3):300-302. doi: 10.1016/j.diabet.2018.01.008. Epub 2018 Jan 18.

Authors

H S Brink¹, M Alkemade², A J van der Lely², J van der Linden³

Affiliations

¹ Department of internal medicine, Maasstad Hospital, P.O. Box 9100, 3007 CA, Rotterdam, The Netherlands. Electronic address: brinkH@maasstadziekenhuis.nl.
² Department of internal medicine, Erasmus University MC, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
³ Department of internal medicine, Maasstad Hospital, P.O. Box 9100, 3007 CA, Rotterdam, The Netherlands.

PMID: 29422358
DOI: 10.1016/j.diabet.2018.01.008

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adult
Diabetes, Gestational / epidemiology
Diabetes, Gestational / prevention & control*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Incidence
Metformin / therapeutic use*
Pregnancy
Treatment Outcome
Young Adult

Substances

Hypoglycemic Agents
Metformin